All the news Showing 9 of 639 articles from: Hepatitis CGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Genetic variation associated with response to hepatitis C therapy in HIV co-infected patients Michael Carter / 05 May 2011 The presence of a genetic variation in the IL28B gene is associated with better response rates to hepatitis C therapy in patients who are co-infected with HIV and hepatitis C, Spanish investigators ... HIV treatment preserves CD4 cell count during and after HCV therapy in co-infected patients Michael Carter / 03 May 2011 Antiretroviral therapy helps preserve the CD4 cell counts of HIV-positive patients undergoing treatment for hepatitis C, Austrian investigators report in the June 15th edition of the Journal of Infectious Diseases. Treatment with ... New hepatitis C drugs pose many questions Keith Alcorn / 08 April 2011 Even before new hepatitis C drugs come to market later this year, the vast array of hepatitis C antivirals currently in clinical trials is opening up new horizons for treatment of hepatitis ... Treatment breaks lead to fibrosis in HIV/HCV-co-infected patients Michael Carter / 07 April 2011 Interrupting HIV therapy is associated with the progression of liver damage in patients co-infected with HIV and hepatitis C, Canadian investigators report in the online edition of AIDS. Taking a break from ... Good survival rates for HIV/HCV-coinfected patients with compensated cirrhosis Michael Carter / 14 March 2011 Medium-term survival rates in patients co-infected with HIV and hepatitis C who have compensated cirrhosis are good and comparable to those seen in hepatitis C-mono-infected individuals, Spanish investigators report in the online edition ... High rate of HCV reinfection after treatment of acute infection in Amsterdam gay men Keith Alcorn / 10 March 2011 Just over one-quarter of gay men with HIV successfully treated for acute hepatitis C infection became reinfected with hepatitis C within two years, almost all with a different genotype, Amsterdam doctors reported last ... Telaprevir works well for people with HIV/HCV co-infection Liz Highleyman / 02 March 2011 The experimental hepatitis C virus (HCV) protease inhibitor telaprevir, used with pegylated interferon plus ribavirin, produced good virological response in the first study of HIV/HCV co-infected individuals, according to interim data presented on Wednesday ... 9% prevalence of hepatitis C co-infection among UK HIV patients Michael Carter / 14 February 2011 Just under 9% of HIV-positive individuals in the UK are co-infected with hepatitis C virus, investigators report in the Journal of Viral Hepatitis. “In comparison with other large cohort studies, the ... Good outcomes among HIV-positive patients having a liver transplant due to cancer Michael Carter / 31 January 2011 HIV-positive patients who have a liver transplant because of liver cancer can have good outcomes, French research published in the February edition of Hepatology shows. The study compared rates of overall survival ... ← Prev1...6061626364Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Transmission and prevention Diagnosis and monitoring Disease course and symptoms HCV and coinfections Living with HCV Treatment issues Side effects Therapies Liver transplants Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive